Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Hospital General de Castellón
Castelló de la Plana, EspañaPublicaciones en colaboración con investigadores/as de Hospital General de Castellón (1)
2020
-
HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies
Annals of Oncology, Vol. 31, Núm. 9, pp. 1186-1197